Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
Preparing for Future Trends in Cancer Care
ACCC Conference
April 2011, Vol 2, No 2
Read More
NCCN Expert Panel Considers Value, Utilization of Molecular Testing in Clinical Practice
By
Lee N. Newcomer, MD, MHA
NCCN Conference
April 2011, Vol 2, No 2
Read More
Prominent Oncologist Applauds First Conference of the Association of Value-Based Cancer Care
April 2011, Vol 2, No 2
Interview with Al B. Benson, III, MD, FACP
Read More
Successful Strategies for Drug Cost-Containment in Oncology Practice
HOPA Conference
,
Oncology Practice
April 2011, Vol 2, No 2
Read More
Perception Versus Actual Testing for KRAS
By
Janna Radtchenko
Oncology
November/December 2010, Vol 1, No 6
Both practice guidelines and thought leaders increasingly recommend biomarker tests for optimization of cancer care; there is, however, a gap between these recommendations, the way physicians practice, and the way they think they practice.
Read More
Teasing Out Value in Healthcare Spending Variations
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
At the request of the US Secretary of Health and Human Services, the Institute of Medicine (IOM) will conduct a study on national variation in healthcare spending and utilization for individuals with Medicare, Medicaid, private insurance, or no insurance.
Read More
Shedding Tiers for Better Value
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
Read More
Blood-Use Program Injects Clinical, Fiscal Control
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
A blood-use protocol program at Loyola University Hospital in Chicago has lowered the amount of blood products transfused per patient, which in turn has led to greater patient safety and lowered costs, according to research presented at the College of American Pathologists annual meeting in Chicago.
Read More
Free Is Good, Not Great, When It Comes to Screening
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
Removing payment for health insurance deductibles leads to increased, although modest, improvements in the rates of screening for conditions such as cancer and elevated cholesterol (Meeker D, et al. Health Serv Res. 2010. Online doi:10.1111/j.1475-6773.2010.01188.x).
Read More
CT Screening Shows Dramatic Benefit in Lung Cancer
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
A study comparing the use of computed tomography (CT) versus standard chest x-rays for screening those at high risk for lung cancer found that CT screening resulted in 20% fewer deaths from the disease.
Read More
Page 319 of 330
316
317
318
319
320
321
322
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins
Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma